SAN DIEGO, Feb. 24, 2020 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today reported financial results for the fourth quarter and full year ended December 31, 2019 and provided an update on its recent corporate activities and outlook. "I am pleased to report 2020 is off to a strong start as we have substantially completed our actions to re

SAN DIEGO, Feb. 24, 2020 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Elaine D. Sun has been appointed senior vice president and chief financial officer, effective March 2, 2020. Ms. Sun will succeed Laurie Stelzer, who has resigned to pursue another opportunity. 

ALPHARETTA, Ga., Feb. 24, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced the U.S. Food and Drug Administration (FDA) has cleared for marketing its new, 80-Watt COOLIEF* Radiofrequency (RF) system for neurological lesion procedures. This easy-to-use system, comprised of a newly designed RF generator, peristaltic pump and therapy cables, enables phy

MADISON, Wis., Feb. 24, 2020 /PRNewswire/ -- Exact Sciences Corporation (NASDAQ: EXAS) (the "Company") today announced an underwritten public offering of $850 million aggregate principal amount of convertible senior notes due 2028 (the "Notes") pursuant to an effective shelf registration statement filed with the Securities and Exchange

DUBLIN, Feb. 24, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will present at the Cowen and Co

WASHINGTON, Feb. 24, 2020 /PRNewswire/ -- The National Resident Matching Program® (NRMP®) has released Results and Data Specialties Matching Service, 2020 Appointment Year, an annual report of physician Fellowship Matches conducted by the NRMP Specialties Matching Service® (SMS®).  The report shows 12,042 active applicants with rank order list

HOLLAND, Ohio, Feb. 24, 2020 /PRNewswire/ -- Dreamscape Media, the publishing and entertainment arm of Midwest Tape, today announced the release of DO NO HARM: THE OPIOID EPIDEMIC, a multimedia educational series that chronicles the progression of what experts deem the "worst man-made public health epidemic in American history." Documented through the poignant stori

EXTON, Pa., Feb. 24, 2020 /PRNewswire/ -- Frontage Holdings Corporation ( "Frontage" or the "Group", 1521.HK), a contract research organization ("CRO") providing integrated, science-driven, product development services, is pleased to announce the expansion of  its bioanalytical laboratories in Exton, PA, through its wholly-owned

CLEVELAND, Feb. 24, 2020 /PRNewswire/ -- CHAMPS Oncology, an industry leader in cancer registry operations, today launched an online education session "2020 Cancer Program Insights - Optim

FORT WORTH, Texas, Feb. 24, 2020 /PRNewswire/ -- Eyevance Pharmaceuticals (Eyevance), committed to developing and commercializing innovative and impactful ophthalmic products, is pleased to announce the appointment of Julie Speed to the position of Chief Commercial Officer. In her new role, Ms. Speed will be responsible for developing